Your browser doesn't support javascript.
loading
Inhibition of CX3CR1 reduces cell motility and viability in pancreatic adenocarcinoma epithelial cells.
Stout, Matthew C; Narayan, Shilpa; Pillet, Emily S; Salvino, Joseph M; Campbell, Paul M.
Afiliação
  • Stout MC; Department of Pharmacology & Physiology, College of Medicine, Drexel University, 245 North 15th Street, MS 488, Philadelphia, PA 19102, USA. Electronic address: Matthew.Stout@DrexelMed.edu.
  • Narayan S; Department of Pharmacology & Physiology, College of Medicine, Drexel University, 245 North 15th Street, MS 488, Philadelphia, PA 19102, USA. Electronic address: shilpanarayan01@gmail.com.
  • Pillet ES; Department of Pharmacology & Physiology, College of Medicine, Drexel University, 245 North 15th Street, MS 488, Philadelphia, PA 19102, USA. Electronic address: esp48@drexel.edu.
  • Salvino JM; Molecular and Cellular Oncogenesis Program, Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA. Electronic address: jsalvino@wistar.org.
  • Campbell PM; Department of Pharmacology & Physiology, College of Medicine, Drexel University, 245 North 15th Street, MS 488, Philadelphia, PA 19102, USA. Electronic address: Pmc63@drexel.edu.
Biochem Biophys Res Commun ; 495(3): 2264-2269, 2018 01 15.
Article em En | MEDLINE | ID: mdl-29274778
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Movimento Celular / Sobrevivência Celular / Carcinoma Ductal Pancreático / Receptor 1 de Quimiocina CX3C Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Movimento Celular / Sobrevivência Celular / Carcinoma Ductal Pancreático / Receptor 1 de Quimiocina CX3C Idioma: En Ano de publicação: 2018 Tipo de documento: Article